These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8464503)

  • 1. Synergen trims sails to survive.
    Roberts J
    Nature; 1993 Apr; 362(6421):577. PubMed ID: 8464503
    [No Abstract]   [Full Text] [Related]  

  • 2. Commercializing nanotechnology.
    Mazzola L
    Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
    [No Abstract]   [Full Text] [Related]  

  • 3. First U.S.-Russian business venture in closed nuclear city.
    Lopatto J; Wilkes B
    Health Phys; 2004 Feb; 86(2):212-3. PubMed ID: 14744060
    [No Abstract]   [Full Text] [Related]  

  • 4. Partnerships between patients, medicine, and the biotechnology industry.
    Kent A; Tambuyzer E
    Nat Biotechnol; 1999 Oct; 17(10):935. PubMed ID: 10504676
    [No Abstract]   [Full Text] [Related]  

  • 5. Winners and losers in merger mania.
    Niiler E
    Nat Biotechnol; 1999 Nov; 17(11):1058. PubMed ID: 10545903
    [No Abstract]   [Full Text] [Related]  

  • 6. Strategic alliances in the Australian biotechnology industry. A comparative view.
    Scott-Kemmis D; Darling T; Stark P
    Aust J Biotechnol; 1988 Sep; 2(2):122-6. PubMed ID: 2485325
    [No Abstract]   [Full Text] [Related]  

  • 7. TBA's structure and focus confuse investors. Thermo BioAnalysis.
    Alper J
    Nat Biotechnol; 1999 Jan; 17(1):13-4. PubMed ID: 9920253
    [No Abstract]   [Full Text] [Related]  

  • 8. Systems biology, incorporated?
    Thiel K
    Nat Biotechnol; 2006 Sep; 24(9):1055-7. PubMed ID: 16964202
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-border biotech.
    Friedman YE; Seline RS
    Nat Biotechnol; 2005 Jun; 23(6):656-7. PubMed ID: 15940229
    [No Abstract]   [Full Text] [Related]  

  • 10. Number crunching.
    Nat Biotechnol; 2003 Aug; 21(8):831. PubMed ID: 12894180
    [No Abstract]   [Full Text] [Related]  

  • 11. Conflict resolution in the biotech industry.
    Yaroshevsky-Glanville M
    Nat Biotechnol; 2005 Mar; 23(3):391-2. PubMed ID: 15765095
    [No Abstract]   [Full Text] [Related]  

  • 12. A very firm handshake: biotech's growing negotiating power.
    Thiel KA
    Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058
    [No Abstract]   [Full Text] [Related]  

  • 13. Shareholders flex their muscles.
    Thiel K
    Nat Biotechnol; 2008 Jan; 26(1):19-21. PubMed ID: 18183007
    [No Abstract]   [Full Text] [Related]  

  • 14. Utilizing technological advances to grow molecular imaging clinical services: industry perspective.
    Schubert S
    J Nucl Med; 2008 Jun; 49(6):63N-65N. PubMed ID: 18511832
    [No Abstract]   [Full Text] [Related]  

  • 15. Five attributes of a successful manager in a research organization.
    Wong GH
    Nat Biotechnol; 2006 Sep; 24(9):1171-4. PubMed ID: 16964236
    [No Abstract]   [Full Text] [Related]  

  • 16. Reverse mergers attract top-tier biotechs in sluggish IPO market.
    Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):598-9. PubMed ID: 16763574
    [No Abstract]   [Full Text] [Related]  

  • 17. Marriage guidance for collaborators.
    Hogan J
    Med Device Technol; 2005 Mar; 16(2):25-6. PubMed ID: 15828497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partnering for better microbial diagnostics.
    Perkins MD; Small PM
    Nat Biotechnol; 2006 Aug; 24(8):919-21. PubMed ID: 16900130
    [No Abstract]   [Full Text] [Related]  

  • 19. US wary of South Korean plans for Californian biocenter.
    Niiler E
    Nat Biotechnol; 2002 Apr; 20(4):321. PubMed ID: 11923819
    [No Abstract]   [Full Text] [Related]  

  • 20. The biotechnology bubble machine.
    Rasnick D
    Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.